Lifemd, Inc. · NASDAQ:LFMD
Lifemd — Investor Presentation (November 2022)
18 slides from Lifemd's investor presentation, Nov 14, 2022
Slide 1: LifeMD: The Doctor Will See You Now
ifeMD The Doctor Will See You Now” November 2022 oat ae Lifemot @ Welcome to LifeMD, Evan! Explore your ifeMD dashboord, Seeaprovider g asap Todor Tomorrow Use my discount card
Slide 2: Important Cautions Regarding Forward-Looking Statements
Important Cautions Regarding Forward-Looking Statements This presentation includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended; Section 21E of the Securities Exchange Act of 11934, as amended; and the safe harbor provision of the U.S. Privat
Slide 3: Our Mission
Our Mission Empower people to live healthier lives by increasing access to affordable, high quality virtual and in-home healthcare
Slide 4: LifeMD At A Glance
LifeMD At A Glance A transformational year, including new brands and partnerships, heightened focus on subscription-based virtual care platform, and expected year-end adjusted EBITDA profitability. $125m 650k’ 200+ 130+ 149% 2022E Patient Conditions Patient Care '21 Revenue Revenue Consultations Tre
Slide 5: Our Patient-Centric Approach
Our Patient- Centric Approach LifeMD's integrative platform elevates the healthcare experience with seamless, end-to-end care spanning diagnosis, medication delivery, and ongoing care. Our patients receive care that is thoughtful, convenient, and affordable. Powered and delivered by LifeMD’s robust
Slide 6: Our Growing LifeMD Ecosystem
Our Growing Life!\ViD Ecosystem Powered by Strong Partners & Integrations D 50-State Telehealth Platform Marketing & E-Commerce Lab Services Pharmacy Adjudication & Cash-Pay Medications Data & Analytics Customer Service
Slide 7: Facilitating The Future Of Virtual-First, In-Home Healthcare
Facilitating The Future Of Virtual-First, In-Home Healthcare WwW Diagnostics & & Prescription fz Advanced Patient In-Home Labs Discount Card ie amen Education ons TT) a sn & Wearables* Routines fay rece , — InHome Supplement Clinical Virtual Consult: PP Inga M9 pre onsets | Health Tools & Lifestyle
Slide 8: A Telehealth Platform Trusted By Over 650k Patients
A Telehealth Platform Trusted By Over 650k Patients @ Poa} Best-in-Class Providers We attract and invest in amazing medical providers that deliver incredible patient experiences.' Q Marketing & Data Analytics Deep expertise in performance marketing, supported by a strong data & analytics platform. ~
Slide 9: Best-In-Class Providers
Best-In-Class Providers Health Care Professionals 50 state coverage by LifeMD affiliated doctors and NPs Leadership Deep experience in virtual and brick-and- mortar primary and urgent care Multi-State Coverage 75% of clinicians Treatments Comprehensive, virtual care for hundreds of are licensed in c
Slide 10: Experts In Marketing & Analytics
Experts In !Viarketing & Analytics (Vj Proprietary technology platform that enables flexible acquisition strategies © _~130 person call center in Greenville, SC that drives new acquisition and high touch patient care jy Custom built analytics platform that enables real- time reporting and decision m
Slide 11: Proprietary & Scalable Tech Stack
Proprietary & Scalable Tech Stack © Designed to support a diverse portfolio of DTC and B2B telehealth product and service offerings ® Integrations with Quest, LabCorp (Q4 ‘22), EMR, multiple pharmacies, in-home tools, symptom checker, prescription discount card, and more © Designed with a compliance
Slide 12: Our Brands
Our Brands ~$250B market size LifemD Primary Care Primary care, urgent care, chronic condition management, and wellness. ~$44B arto NAMA® Dermatology Dermatology treatment, prescription medications, and patented» OTC products. ~$13.5B market size Allergy & Asthma Treatment, prescription medications,
Slide 13: Rapidly Expanding Telehealth Presence
Rapidly Expanding Telehealth Presence DTC Telemedicine Subscription-based treatment+Rx offerings Established, wholly-owned brands with large customer base E.D., pain, dermatology, insomnia, allergy & asthma Virtual Primary Care + Services include primary care, urgent care, and chronic condition mana
Slide 14: Virtual Primary Care (VPC) Has Hit Its Stride And Is Rapidly Expanding
Virtual Primary Care (VPC) Has Hit Its Stride And Is Rapidly Expanding End of Period VPC Patients 6000 5,000 5000 4000 VPC Patients 3000 2,400 2000 Apr-22 May-22 Jun-22 Jul-22 03 22 04 226
Slide 15: Early Mover Advantage Has Enabled Incredible Growth
$122M-$128M Early Mover Advantage, Supported By A Patient-Centric Approach, Has Enabled Incredible Growth $93M $122M-$128M 2022 Revenue Forecast 149% $37M YoY Revenue Growth in ‘21 650K+ Patients & Customers To-Date 2021P -=-= 149% ----!
Slide 16: Meaningful Improvement in Cash Burn & Bottom-Line Performance
Meaningful Improvement in Cash Burn & Bottom-Line Performance; Consolidated Profitability by Q4 ‘22 Consolidated Adjusted EBITDA ($ millions) $5.0 $20 $0.0 -$5.0 -$10.0 $15.0 —= 22021 032021 42021 © Q12022 © a22022 © 03 2022-04 2022E Note: Consolidated Adjusted EBITDA includes Telehealth and WorkSim
Slide 17: Rapidly Accelerating Gross Margins And Increasing Leverage On Marketing Spend
Rapidly Accelerating Gross Margins And Increasing Leverage On Marketing Spend Driving Pathway To Profitability Telehealth Gross Margin % Marketing Cost as % of Sales 35 125% 80% 100% 78% 2 100% 81% 1% 76% Ne 75% . 29 = 75% 74% 26 50% 72% 70% 23 25% | 20 022021 32023 a42021 012002 022022 c2202 0% Net
Slide 18: Management Team
Management Team & Justin Schreiber Alex Mironov Chief Executive President Officer Dr. Tony Puopolo James Porte President, LifeMD SVP of Patient Affliated P.C’s Experience Board of Directors & 3 Justin Schreiber Stefan Galluppi Chairman Naveen Bhatia John Strawn 2 Marc Benathen Chief Financial Office